2012
DOI: 10.1002/14651858.cd008585.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Beta2-adrenoceptor agonists for dysmenorrhoea

Abstract: Appendix 1. Menstrual Disorders and Subfertility Group (MDSG) Specialised Register The MDSG search string is dated from inception of database until present.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
4
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 30 publications
0
4
0
1
Order By: Relevance
“…Primary dysmenorrhea (PDM) is defined as the regular onset of painful, spasmodic cramping in the lower abdomen in women with normal pelvic anatomy. 10,14,15,18 Despite the negative impact of menstrual pain on multiple aspects of women's personal lives, most neuroimaging studies on PDM focus on the relationship between menstrual pain and brain abnormalities. Given that pain is not only a sensory experience but also an emotional event, 12,22,23 the effects of menstrual pain on the psychological and affective states of women, such as empathy, should also be considered.…”
Section: Introductionmentioning
confidence: 99%
“…Primary dysmenorrhea (PDM) is defined as the regular onset of painful, spasmodic cramping in the lower abdomen in women with normal pelvic anatomy. 10,14,15,18 Despite the negative impact of menstrual pain on multiple aspects of women's personal lives, most neuroimaging studies on PDM focus on the relationship between menstrual pain and brain abnormalities. Given that pain is not only a sensory experience but also an emotional event, 12,22,23 the effects of menstrual pain on the psychological and affective states of women, such as empathy, should also be considered.…”
Section: Introductionmentioning
confidence: 99%
“…Overall the evi dence supporting their use is very poor and they are associated with significant sideeffects, therefore their use is not recom mended. 12 …”
Section: Other Pharmacological Treatmentsmentioning
confidence: 99%
“…Eldeki veriler, dismenore tedavisinde Beta2-adrenoseptörün kullanımı hakkında güvenli karar vermeyi sağlamak için yeterli kanıt olmadığı göstermektedir (I-D). 43…”
Section: Tibbi̇ Tedavi̇unclassified